Company Search:
Advanced Search
Sponsored Links
Dbv Technologies Company Snapshot
Dbv Technologies operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other companies in this sector in France: Onxeo SA (2015 sales of 3.48 million Euro [US$3.70 million] of which 88% was Orphan Products Oncology), Nicox SA (9.96 million Euro [US$10.59 million] of which 100% was Sale of Pharmaceuticals), and Biocorp Sa (2.46 million Euro [US$2.62 million] ).

Sales Analysis. Dbv Technologies reported sales of 6.17 million Euro (US$6.55 million) for the year ending December of 2015. This represents an increase of 29.5% versus 2014, when the company's sales were 4.76 million Euro. This was the fourth straight year of sales growth at Dbv Technologies.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dbv Technologies
  Stock Performance Chart for Dbv Technologies
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 63.41
(Figures in Euro)
1 Week -4.5%   13 Weeks -5.2%  
4 Weeks -2.6%   52 Weeks 32.8%  
Dbv Technologies Key Data:
  Ticker: DBV Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 6,166,000
(Year Ending Jan 2016).
Employees: 91
  Currency: Euro Market Cap: 1,534,847,230
  Fiscal Yr Ends: December Shares Outstanding: 24,205,129
  Share Type: Ordinary Closely Held Shares: 2,130,097
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.